Phase II study of S-1 in patients with gemcitabine-refractory advanced biliary tract cancer.
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Biliary cancer
- Focus Therapeutic Use
- 12 May 2016 Last checked against University Hospital Medical Information Network - Japan record.
- 02 Dec 2009 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 05 Dec 2007 New trial record.